Skip to main content

Table 3 Postoperative data of the studied gastrectomy groups

From: Oncological outcomes of laparoscopic versus open gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a retrospective multicenter study

Variables

OG group (n = 43)

LG group (n = 41)

P value

Hospital stay, days (mean ± SD)

8.11 ± 2.44

4.75 ± 5.17

0.026

Mortality, no. (%)

4 (9.7%)

2 (4.6%)

0.36

Postoperative complications, no. (%)

7 (17.1%)

8 (19.5%)

0.16

Type of surgical complications, no. (%)

• Abdominal collection

0 (0%)

2 (4.7%)

0.128

• Esophagojejunal leak

4 (9.8%)

3 (7%)

• Gastrointestinal bleeding

1 (2.4%)

0 (0%)

• Wound infection

0 (0%)

1 (2.3%)

• Intraperitoneal bleeding

1 (2.4%)

0 (0%)

• Pancreatic leak

0 (0%)

2 (4.7%)

Type of medical complications, no. (%)

• Urinary tract infection

2 (4.6 %)

0 (0%)

0.227

• Enteritis

1 (2.3%)

0 (0%)

• Gastrointestinal bleeding

0 (0%)

1 (2.4%)

• Pleural effusion

(7%)

1 (2.4%)

• Pulmonary embolism

1 (2.3%)

0 (0%)

• Sepsis

0 (0%)

1 (2.4%)

Clavien-Dindo class, no. (%)

• Grade II

2 (4.9%)

8 (18.6%)

0.026

• Grade IIIA

1 (2.4%)

4 (9.3%)

• Grade IIIB

2 (4.9%)

0 (0%)

• Grade IVA

1 (2.4%)

0 (0%)

• Grade V

2 (4.9%)

0 (0%)

Reintervention, no. (%)

2 (4.7%)

2 (4.9%)

0.96

  1. NOTE: LG laparoscopic gastrectomy, OG open gastrectomy, SD standard deviation